Treatment Option for COVID-19

Authors

  • Mohammad Zulkifle HoD, Department of Kulliyate Tib, National Institute of Unani Medicine, Kottigepalya, Magadi Main Road, Bengaluru, Karnataka, India
  • Sayed Tauleha P.G. Scholar, Department of Kulliyate Tib, National Institute of Unani Medicine, Kottigepalya, Magadi Main Road, Bengaluru, Karnataka, India
  • Zubair Sharif Assistant Professor, Government Unani Medical College, Chennai, Tamil Nadu, India

Keywords:

COVID-19, herbal medicine, Iranian medicine, Unani medicine

Abstract

Since the emergence of COVID-19 in Wuhan, China, it has been a challenge for medical fraternity in respect of prevention and treatment. Various treatment modules are in vogue but all are supportive and based on hit and trial design. Hardly if any from advanced stage is recovered. Outcome with supportive and assumptive treatments is better and almost all recovered from COVID-19 infection are from mild to moderate categories. Presently Hydroxychloroquine, Doxycycline, Ivermectin, Dexamethasone, other antibiotics and ventilation are prevalent treatment modalities in different countries. In India and China, alternate therapists are also doing their efforts against containment of COVID-19. Unani system is one of AYUSH components in India. A decoction of Unani medicine has got fame for its efficacy in Maharashtra state of India. Some evidences of efficacy of Traditional Chinese Medicine (TCM) are also documented from China. In present study, efficacy of a Unani formulation in halting the progress and curative potential is documented.

Author Biographies

  • Mohammad Zulkifle, HoD, Department of Kulliyate Tib, National Institute of Unani Medicine, Kottigepalya, Magadi Main Road, Bengaluru, Karnataka, India
    HoD, Department of Kulliyate Tib, National Institute of Unani Medicine, Bengaluru, India-560091
  • Sayed Tauleha, P.G. Scholar, Department of Kulliyate Tib, National Institute of Unani Medicine, Kottigepalya, Magadi Main Road, Bengaluru, Karnataka, India
    Research Scholar, National Institute of Unani Medicine, Bengaluru
  • Zubair Sharif, Assistant Professor, Government Unani Medical College, Chennai, Tamil Nadu, India

    Assistant Professor, Government Unani Medical College, Chennai, India 600106.

References

Balgopal M, Bondy C. Antigenic Shift and Drift. Science Teacher. Feb 1, 2011; 78(2): 42–46p.

Payne S. Family Coronaviridae. Viruses. 2017; 149–158p.

Hani C, Trieu NH, Saab I, Dangeard S, Bennani S, Chassagnon G, Revel MP. COVID-19 Pneumonia: A Review of Typical CT Findings and Differential Diagnosis. Diagn Interv Imaging. Apr 3, 2020; 101(5): 263–268p.

Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). In StatPearls [internet] 2020 Mar 8. StatPearls Publishing.

Q&A on Coronaviruses (COVID-19). [Internet]; 2020 [Cited 2020 July 23]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/q-a-coronaviruses

Tobaiqy M, Qashqary M, Al-Dahery S, Mujallad A, Hershan AA, Kamal MA, Helmi N. Therapeutic Management of COVID-19 Patients: A Systematic Review. Infection Prevention in Practice (IPIP). Apr 17, 2020; 2(3): 100061p.

Rabby MI. Current Drugs with Potential for Treatment of COVID-19: A Literature Review. J Pharm Pharm Sci. Apr 4, 2020; 23(1): 58–64p.

Sina I. Kulliyate Qanoon. (Urdu Translation by Kabiruddin HM). New Delhi: Idara Kitabul Shifa; 2015.

Razi AMIZ. Kitabul Hawi. Vol. 17. New Delhi: CCRUM; 2008.

Majoosi AIA. Kamilus Sanaa. New Delhi: Idara Kitabul Shifa; 2010.

Ibn-Sina. SR. Al-Qanoon Fit Tib (Urdu Translation by Ghulam Husnain Kantoori). New Delhi: Idara Kitabul Shifa; YNM.

Ibn Rushd AW. Kitabul Kulliyat. Lahore: Maktaba Daniyal; 2017.

Ibn Zohar AMA. Kitabu Al-Taiseer. (Urdu Translation). New Delhi: CCRUM; 1986.

Itrat M. Evaluation of Tiryaq Wabai as an Immunostimulator in Elderly Persons. Dissertation. Bangalore: RGUHS; 2011.

Kirmani NAA. Sharah Asbabwa Alamat (Urdu Translation by Kabiruddin A). New Delhi: Idara Kitabul Shifa; 2009.

Rampuri AHN. Khazainul Adviya. New Delhi: Idara Kitabul Shifa; YNM.

Hasan NM, Al Sorkhy MA, Al Battah FF. Ziziphus jujube (ennab) of the Middle East, Food and Medicine. Unique J Ayurvedic Herb Med. 2014; 2(6): 7–14p.

Ghobadi A, Amini Behbahani F, Yousefi A, TaghaviShirazi M, Behnoud N. Medicinal and Nutritional Properties of Ziziphus jujuba Mill. in Traditional Persian Medicine and Modern Phytotherapy. Crescent J Med Biol Sci. 2019; 6(2): 146–50p.

Al Undlusi ZAI. Aljame Ul Mufradat Al Advia Wal Aghziya. (Urdu Translation). Vol. 2. New Delhi: CCRUM; 2000.

Al Undlusi ZAI. Aljame Ul Mufradat Al Advia Wal Aghziya. (Urdu Translation). Vol. 3. New Delhi: CCRUM; 1999.

Jamkhande PG, Barde SR, Patwekar SL, Tidke PS. Plant Profile, Phytochemistry and Pharmacology of Cordia dichotoma (Indian Cherry): A Review. Asian Pac J Trop Biomed. Dec 1, 2013; 3(12): 1009–12p.

Prajapati SK, Kar M, Maurya SD, Pandey R, Dhakar RC. Exploring Phytochemicals and Pharmacological Uses of Cordia dichotoma (Indian Cherry): A Review. J Drug Deliv Ther. Nov 28, 2017; 7(6): 125–31p.

Fathiazad F, Hamedeyazdan S. A Review on Hyssopus officinalis L.: Composition and Biological Activities. Afr J Pharm Pharmacol. 2011; 5(17): 1959–1966p.

Al-Awwadi NA. Potential Health Benefits and Scientific Review of Ginger. J Pharmacognosy Phytother. Jul 31, 2017; 9(7): 111–6p.

Badgujar SB, Patel VV, Bandivdekar AH, Mahajan RT. Traditional Uses, Phytochemistry and Pharmacology of Ficuscarica: A Review. Pharm Biol. Nov 1, 2014; 52(11): 1487–503p.

Roshan A, Verma NK, Kumar CS, Chandra V, Singh DP, Panday MK. Phytochemical Constituent, Pharmacological Activities and Medicinal Uses through the Millenia of Glycyrrhizaglabra Linn: A Review. Int Res J Pharm. 2012; 3(8): 45–55p.

Baghdadi IH. Kitab al Mukhtarat Fit Tib. Vol. II. New Delhi: CCRUM; 2005.

Kabiruddin HM. Hummiyate Qanoon. New Delhi: Aejaz Publishing House; 2007.

Khan HMA. Akseere Aazam. New Delhi: Idara Kitabul Shifa; 2011.

Qumri AMH. Gina Muna. New Delhi: CCRUM; 2008.

Downloads

Additional Files

Published

2021-04-06

Issue

Vol. 10 No. 1 (2021)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.